# Study Comparing Two Treatments in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

> **NCT01528163** · PHASE2 · COMPLETED · sponsor: **Cliniques universitaires Saint-Luc- Université Catholique de Louvain** · enrollment: 101 (actual)

## Conditions studied

- Squamous Cell Carcinoma of the Head and Neck

## Interventions

- **DRUG:** Cabazitaxel
- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT01528163
- **Lead sponsor:** Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2017-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01528163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01528163, "Study Comparing Two Treatments in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01528163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*